111 related articles for article (PubMed ID: 8792697)
1. 4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection.
de Boer WA; van Etten RJ; Schade RW; Ouwehand ME; Schneeberger PM; Tytgat GN
Am J Gastroenterol; 1996 Sep; 91(9):1778-82. PubMed ID: 8792697
[TBL] [Abstract][Full Text] [Related]
2. Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection.
de Boer SY; v d Meeberg PC; Siem H; de Boer WA
Neth J Med; 2003 Jun; 61(6):218-22. PubMed ID: 12956102
[TBL] [Abstract][Full Text] [Related]
3. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
[TBL] [Abstract][Full Text] [Related]
4. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
5. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
[TBL] [Abstract][Full Text] [Related]
6. Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection.
Dore MP; Graham DY; Mele R; Marras L; Nieddu S; Manca A; Realdi G
Am J Gastroenterol; 2002 Apr; 97(4):857-60. PubMed ID: 12003419
[TBL] [Abstract][Full Text] [Related]
7. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
[TBL] [Abstract][Full Text] [Related]
8. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
[TBL] [Abstract][Full Text] [Related]
10. Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection.
Harris AW; Pryce DI; Gabe SM; Karim QN; Walker MM; Langworthy H; Baron JH; Misiewicz JJ
Aliment Pharmacol Ther; 1996 Dec; 10(6):1005-8. PubMed ID: 8971302
[TBL] [Abstract][Full Text] [Related]
11. A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule.
de Boer WA; van Etten RJ; Schneeberger PM; Tytgat GN
Am J Gastroenterol; 2000 Mar; 95(3):641-5. PubMed ID: 10710051
[TBL] [Abstract][Full Text] [Related]
12. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Buzás György M; Székely E; Illyés G; Széles I
Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
[TBL] [Abstract][Full Text] [Related]
13. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
de Boer WA; Haeck PW; Otten MH; Mulder CJ
Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
[TBL] [Abstract][Full Text] [Related]
14. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
15. Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection.
Graham DY; Hoffman J; el-Zimaity HM; Graham DP; Osato M
Aliment Pharmacol Ther; 1997 Oct; 11(5):935-8. PubMed ID: 9354203
[TBL] [Abstract][Full Text] [Related]
16. Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection.
Korman MG; Bolin TD; Nicholson FB; Engelman JL
Helicobacter; 1998 Sep; 3(3):202-5. PubMed ID: 9731992
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
de Boer WA; van Etten RJ; Lai JY; Schneeberger PM; van de Wouw BA; Driessen WM
Helicobacter; 1996 Sep; 1(3):145-50. PubMed ID: 9398895
[TBL] [Abstract][Full Text] [Related]
18. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection.
Trevisani L; Sartori S; Caselli M; Ruina M; Verdianelli G; Abbasciano V
Am J Gastroenterol; 1998 Mar; 93(3):390-3. PubMed ID: 9517646
[TBL] [Abstract][Full Text] [Related]
19. The influence of pretreatment on cure rates of Helicobacter pylori eradication.
Janssen MJ; Laheij RJ; Jansen JB; de Boer WA
Neth J Med; 2004 Jun; 62(6):192-6. PubMed ID: 15460498
[TBL] [Abstract][Full Text] [Related]
20. One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection.
de Boer WA; van Etten RJ; Schade RW; Ouwehand ME; Schneeberger PM; van Unnik AJ; Tytgat GN
Aliment Pharmacol Ther; 1997 Feb; 11(1):109-12. PubMed ID: 9042982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
